D.E. Shaw & Co’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $619K | Sell |
|
|||||
|
2023
Q1 | $8.49M | Sell |
|
|||||
|
2022
Q4 | $12.2M | Buy |
|
|||||
|
2022
Q3 | $4.17M | Sell |
|
|||||
|
2022
Q2 | $7.89M | Buy |
|
|||||
|
2022
Q1 | $1.83M | Buy |
|
|||||
|
2021
Q4 | $1.27M | Buy |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $557K | Sell |
|
|||||
|
2020
Q2 | $3.41M | Buy |
|
|||||
|
2020
Q1 | $399K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $345K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $2.08M | Buy |
|
|||||
|
2018
Q4 | $1.08M | Sell |
|
|||||
|
2018
Q3 | $3.76M | Buy |
|